Tag Archives: essential health benefits

Rx Brand Managers: Will Your Products Be Covered Under Obamacare?

by Tom Norton We are now less than three weeks away from the initial sign up period for Obamacare. After October 1st, the reality of the program and all that it portends for the future of the US pharmaceutical industry will begin to make itself apparent. One area that is of extreme concern to Rx […]
Posted in Guest Blog, healthcare, Legal, Market Access, Regulatory, Strategy | Also tagged , , , , , , , | Leave a comment

No 'One Drug Per Therapeutic Class' for Congress

by Tom Norton As many of you may recall, earlier this year I commented on a section of the new Obamacare law that directed Members of Congress and their staffs to participate in the new healthcare program, effective January 1, 2014.  The theory was that if Congress mandated Obamacare for all Americans, then Members of […]
Posted in Guest Blog, healthcare, Legal, Regulatory, Strategy | Also tagged , , , , , , , , | Leave a comment

Those Amazing 'Gold Plated, Cadillac Care' Drug Programs

by Tom Norton Not too many years ago, while employed by one of America’s leading Rx manufacturers, I remember stepping up to a retail drug store counter to pick up a prescription.  As the pharmacist handed me my script, he said, “Wow.  I don’t know what kind of health insurance you have, but I have […]
Posted in FDA, Global, Guest Blog, healthcare, Legal, Market Access, pricing, Regulatory, Strategy | Also tagged , , , , , , , , , , , , , , , , , | Leave a comment

Are US and Canadian Rx Policies Converging?

by Tom Norton As the US pharmaceutical industry anxiously watches the rapid onset of Obamacare, certainly one of the more pressing issues is the debate over the number of drugs that will be reimbursed in each therapeutic class under the Essential Health Benefits (EHB) program.  To say that this is a critical concern for the […]
Posted in Global, Guest Blog, healthcare, Legal, Market Access, Strategy | Also tagged , , , , , | Leave a comment

Pharma Gains from Rule On Health Insurance Benefits

Recent change likely to boost drug coverage by plans, but with variation in formularies. Health plans offering coverage to individuals and small companies are more likely to cover multiple drugs in each class or category under revised regulations proposed by the Department of Health and Human Services in November. A key change in rules to […]
Posted in healthcare, Legal, Regulatory, Strategy | Also tagged , , , | Leave a comment
  • Categories

  • Meta